Which of the following cholinesterase inhibitors is said to produce more severe muscarinic side effects

Questions 105

ATI RN

ATI RN Test Bank

Drugs for Peripheral Nervous System Questions

Question 1 of 5

Which of the following cholinesterase inhibitors is said to produce more severe muscarinic side effects

Correct Answer: B

Rationale: In this question, the correct answer is B) Neostigmine. Neostigmine is known to produce more severe muscarinic side effects compared to the other cholinesterase inhibitors listed. Neostigmine is a quaternary ammonium compound that acts as a reversible acetylcholinesterase inhibitor. It increases the concentration of acetylcholine at the neuromuscular junction, leading to increased stimulation of both muscarinic and nicotinic receptors. This excess stimulation of muscarinic receptors can result in side effects such as bradycardia, bronchoconstriction, excessive salivation, gastrointestinal disturbances, and sweating. Pyridostigmine and Ambenonium are also cholinesterase inhibitors, but they are less likely to cause severe muscarinic side effects compared to neostigmine. Pyridostigmine is commonly used in myasthenia gravis, while Ambenonium is less frequently used due to its longer duration of action. It is important for healthcare professionals, especially those prescribing or administering these medications, to understand the differences in side effect profiles of cholinesterase inhibitors to ensure safe and effective patient care. Understanding these nuances can help in making informed decisions regarding drug selection and management of potential adverse effects.

Question 2 of 5

Phenylephrine has most prominent

Correct Answer: A

Rationale: Phenylephrine is a sympathomimetic drug that primarily acts on alpha-adrenergic receptors in the peripheral nervous system. Therefore, the correct answer is A) Alpha effects. Phenylephrine's most prominent action is the stimulation of alpha-adrenergic receptors, leading to vasoconstriction and an increase in blood pressure. Option B) Beta1 effects and C) Beta2 effects are incorrect because phenylephrine does not have significant beta-adrenergic receptor activity. Beta1 receptors are primarily located in the heart, influencing heart rate and contractility, while Beta2 receptors are found in the lungs and blood vessels, mediating vasodilation and bronchodilation. Option D) Metabolic effects is also incorrect as phenylephrine does not have direct metabolic effects. Understanding the specific receptor targets of drugs is crucial in pharmacology to predict their physiological effects and potential side effects accurately. In an educational context, knowing the receptor specificity of drugs like phenylephrine is essential for healthcare professionals to make informed decisions about their clinical use. This knowledge helps in understanding the expected therapeutic outcomes and potential adverse effects, contributing to safe and effective patient care.

Question 3 of 5

A 46-year-old woman complained of daytime sleepiness after taking an antihistamine for allergic rhinitis. Which of the following brain regions was most likely involved in the adverse effect of this drug?

Correct Answer: D

Rationale: The correct answer is D: Nucleus basalis of Meynert. The antihistamine likely caused sedation by blocking histamine receptors in the brain. The Nucleus basalis of Meynert is responsible for arousal and wakefulness, so blocking histamine receptors there can lead to daytime sleepiness. A: Nucleus tractus solitarius is involved in autonomic functions like blood pressure and heart rate regulation, not sedation. B: Caudatum is part of the basal ganglia involved in motor control and learning, not sedation. C: Hippocampus is crucial for memory and learning, not sedation.

Question 4 of 5

Which of the following adverse effects were most likely to occur during the first days of therapy with sertraline and diazepam?

Correct Answer: C

Rationale: The correct answer is C: Excessive sedation and drowsiness. Sertraline and diazepam are both central nervous system depressants, which can lead to sedation and drowsiness especially during the initial days of therapy due to the body adjusting to the medication. This is a common side effect of these drugs and can impact the individual's alertness and ability to function normally. Rationale: - A: Excitement and irritability are more commonly associated with stimulant medications, not with sertraline and diazepam. - B: Mental confusion and anterograde amnesia are more commonly seen with benzodiazepines like diazepam, but are not typically the main adverse effects during the first days of therapy. - D: Respiratory depression and apnea are serious side effects of central nervous system depressants, but they are not commonly observed during the initial days of therapy with sertraline and diazepam.

Question 5 of 5

Which of the following drugs would be relatively contraindicated for a patient diagnosed with generalized anxiety disorder?

Correct Answer: D

Rationale: The correct answer is D: Diazepam. Diazepam belongs to the benzodiazepine class of drugs, which can be addictive and have a high potential for abuse. For a patient with generalized anxiety disorder, long-term treatment with benzodiazepines like diazepam is generally discouraged due to the risk of tolerance, dependence, and withdrawal symptoms. Other choices (A, B, C) are commonly used for treating anxiety disorders without the same level of addiction potential as diazepam. Venlafaxine is an SNRI, Buspirone is a non-addictive anxiolytic, and Paroxetine is an SSRI.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions